Event details
Thursday, September 22nd, 2026
1:00 PM – 2:00 PM ET
12:00 PM –
1:00 PM CT
10:00 AM – 11:00 AM PT
*Pre-Registration Required
Live Interactive Webinar
Target audience
This activity is intended for hematologists-oncologists, medical oncologists, NPs, nurses, and other healthcare professionals engaged in the care of patients with Non-Hodgkin Lymphoma (NHL).
Educational objectives
After completing this
activity, the participant should be better able to:
- Explain treatment options focusing on latest developments and new therapies for patients with aggressive NHL, such as DLBCL
- Interpret the clinical significance of new and emerging data on therapies such as antibody-drug conjugates, bispecific antibodies, and CAR-T
- Identify patients who are candidates for newly approved therapies
- Explain the HCP’s role in preparing the patient for therapy, administering treatment, monitoring for and managing side effects
- Identify resources to support patients and their caregivers
Faculty
Brittney Kanngieser, RN, BSN, OCN
Oncology Nurse Case
Manager
Nebraska Medicine
Omaha, NE
Matthew Lunning, DO, FACP – UNMC
Professor
Chief of Hematology, Interim
James O. Armitage,
MD, Chair in Hematological Malignancies
Medical Director, Gene &
Cellular Therapy
Assistant Vice Chancellor of Research
University
of Nebraska Medical Center
Omaha, NE
Meghan McGrath, MSN, AGACNP
Clinical Trial Nurse
Navigator
Clinical Trials Support Center
Blood Cancer United
Washington,
DC
Ashley L. Schmitt, PA-C
Hematology Oncology Physician
Assistant
Nebraska Medicine
Omaha, NE
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Blood Cancer United and Medical Learning Institute Inc. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical EducationMedical Learning Institute Inc (MLI) designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nursing Credit Designation
Approval for nurses has been obtained by the National Office of Blood Cancer United under Provider Number CEP 5832 to award 1.0 continuing education contact hour through the California Board of Registered Nursing.
ILNA Recertification Points
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points in the following ILNA subject areas: Care Continuum (OCN, CBCN, CPHON, AOCNP, ROCN) 0.25*, Foundations of Transplant/HSCT and Cellular Therapy (TCTCN) 0.5*, HSCT and Cellular Therapy Process and Administration (TCTCN) 0.25*, Post Cellular Therapy Management and Education (TCTCN) 0.25*, Quality of Life (TCTCN) 0.25*, Transplant Process and Infusion (TCTCN) 0.25*, Treatment (AOCNP, CBCN, CPHON, OCN, ROCN) 0.5*.
Total points: 1.0
*Note that the course content applies to multiple subject areas across multiple credentials. The numerical value indicated above is the maximum amount of points that can be claimed in each subject area. The total amount of points claimed may not exceed the total amount of nursing continuing professional development (NCPD) or CME awarded from this course and may only apply to the credential you are renewing.
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
Learners must participate in the entire CE activity, complete, and submit the evaluation form to earn credit. Once submitted, the certificate will be generated. If you have questions regarding the receipt of your certificate, please contact via email at [email protected].
Providers
This activity is provided by Blood Cancer United, formerly The Leukemia & Lymphoma Society, and Medical Learning Institute Inc.
Supporters
There is no commercial support associated with this CE activity.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at [email protected].